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SUMMARY 
Objective: To determine the histopathologic correlation of fine needle aspiration cytology FNAC of breast masses 
seen in the department of histopathology of the Federal Medical Center Owo, Southwestern Nigeria. 
Design: This is a 5-year retrospective study of breast lumps seen at Department of Histopathology, Federal Medical 
Centre Owo, a tertiary health care facility in Southwestern Nigeria between January 1 2010 and December 31 2014.  
Participants: All patients who had Fine Needle Aspiration Cytology of Breast lumps with subsequent histological 
confirmation over this period were included in the study. 
Results: In the five years under review (2010-2014), a total of 289 FNAC of breast lumps were done. The aspirates 
were obtained from 275 (95.2%) females and 14 (4.8%) males. There were 161 cases of FNAC with corresponding 
tissue for histological correlation giving a biopsy rate of 55.7%. The sensitivity of FNAC in determining the final 
histologic diagnosis was found to be 99.4% while the specificity was 100%. FNAC was able to determine final his-
tologic diagnosis conclusively in 86.3% of cases. 
Conclusion: We therefore concluded that FNAC is a reliable diagnostic tool of breast lumps in our centre. Being a 
fast and cheap diagnostic tool as highlighted by previous studies, we advocate that clinicians should continue to em-
brace this diagnostic technique in the surgical management of breast lumps. 
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INTRODUCTION 
There is increasing awareness with associated anxiety 
and stress among women, who perceive every symptom 
in breast as cancer, compelling them to seek medical 
advice. It is sometimes difficult to determine whether a 
suspicious lump is benign or malignant simply from 
clinical assessment.1  
 
Due to its increasing incidence, morbidity and mortality 
breast cancer is the commonest malignant tumour re-
sponsible for 18.4% of all female cancers worldwide. 
As it is the leading cause of death from cancer in wom-
en,2,3 the major concern of the surgeon and the respon-
sibility of the surgical pathologist lies in the ability to 
differentiate a benign from a malignant lesion. 
 
Although open surgical biopsy is the ‘gold standard’ for 
diagnosis of palpable breast lesions, in recent years two 
types of minimally invasive breast biopsy techniques, 
core needle biopsy (CNB) and fine needle aspiration 
cytology (FNAC), have become established for the di-
agnostic evaluation of palpable breast lesions.4 A triple 
test consisting of clinical examination, mammography 
and FNAC is considered the gold standard in making a 
definitive assessment of breast lumps.5 
 
In resource poor settings like ours, FNAC comes readily 
useful for its obvious advantages. It is a cheap, fast, and 
reliable diagnostic method. It also reduces the frequency 
of open biopsies.5 Some of the setback of FNAC include 
pain and haematoma formation. It has also been found 
to have the potential to mask radiological assessment 
when done prior to mamography.4 It is also possible that 
the smears may be acellular (no cells are harvested) 
making cytological analysis impossible. These are de-
scribed as inadequate aspirates and rates vary markedly, 
being particularly operator dependent and cases have to 
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We therefore set out to publish our experience in the last 
five years of operating a functional FNAC clinic of the 
breast in the Federal Medical Centre, Owo, Nigeria. 
From our findings, we determine the correlation be-
tween the results of our breast FNAC and corresponding 
tissue biopsy and consequently determine the accuracy 
of our FNAC reporting. 
 
METHODS 
This is a retrospective study conducted at Department of 
Histopathology, Federal Medical Centre, Owo between 
January 1 2010 and December 31 2014. All patients 
who had FNAC of breast lumps with subsequent histo-
logical confirmation over this period were included in 
the study. 
 
Fine needle aspirations were done by pathologists using 
between 10 ml -20 ml syringe with 23 G needle. Smears 
were stained with Haematoxylin and Eosin (H &E), 
Papanicolaou and Giemsa stains. 
 
The cytological diagnoses were then categorized into 
one of five diagnostic categories in accordance with the 
recommendations of the United Kingdom National 
Health Services Breast Screening Programme 
(NHSBSP).3 
 
The cases were reported using a modification of the 
NHB reporting criteria  
C l - Insufficient cells for cytological analysis, i.e. fewer 
than five epithelial cell groups,  
C2 - Cells present all benign; no suspicious features,  
C3 - Cells suspicious but probably benign,  
C4 - Cells suspicious but probably malignant and  
C5 - Definitely malignant.  
 
With this diagnostic protocol, the surgical pathologist is 
able to demonstrate some degree of diagnostic certainty 
and that the surgical pathologist is able to advise the 
surgeon to plan the patient for major breast surgery on 
the basis of the cytological diagnosis alone.6 
 
Histopathological slides of corresponding cytological 
cases were correlated. Based on these findings, the sen-
sitivity, specificity, positive predictive value and nega-
tive predictive value of Fine Needle Aspiration Cytolo-
gy as a test were calculated. 
 
Ethical approval 
Ethical approval for this study was obtained from the 
Ethics and Research committee of the Federal Medical 
Centre, Owo, Nigeria. An ethical clearance certificate 




A total of 289 FNAC were done during the study peri-
od. These were obtained from 275 (95.2%) females and 
14(4.8%) males, giving a male to female ratio of 1:19. 
The right breast was more affected in 146 (50.1%) cas-
es, left breast in 118(40.8%) cases and bilateral in the 
remaining 25(8.7%) cases. In 161 cases, tissue biopsies 
were done giving a biopsy rate of 55.7%. The diagnosis 
of the FNAC as obtained in the NHSBSP guideline is 
given in Table 1 for the total 161 cases that were in-
cluded in our study. 
 
Table 1 Comparison of FNAC and Histologi-
cal diagnosis 




C1 Insufficient 2 (1.2)   - 
C2 Benign 98 (60.9) 113 (70.2) 
C3 Suspicious probably 
Benign        
14 (8.7)   - 
C4 Suspicious probably 
Malignant 
6 (3.7)   - 
C5 Malignant 41 (25.5) 48 (29.8) 
Total  161 (100) 161 (100) 
 
FNAC was able to make correct definitive diagnosis in 
139 cases (86.3%). All 98 cases diagnosed as Benign 
(C2) and those diagnosed as malignant (C5) (41 cases) 
ended up as benign and malignant respectively on histo-
logic examination. 
 
Diagnoses of malignancy were confirmed histologically 
on all 41(100%) cases diagnosed as malignant on 
FNAC, all six (6) cases (100%) diagnosed on FNAC as 
suspicious possibly malignant, and one (1) (7.1%) of 
cases diagnosed as suspicious possibly benign on 
FNAC. There was no case diagnosed as benign on 
FNAC that ended up being malignant on histology. 
 
All 98 (100%) cases diagnosed as benign on FNAC 
ended up being benign on histology while 13(92.9%) 
out of the 14 cases diagnosed as suspicious possibly 
benign also turned out to be benign on histology. The 
two cases that were classified as inadequate for evalua-
tion on FNAC were also found to be benign on histolo-
gy. There were no cases of suspicious possibly malig-
nant (C4) or straight forward malignant (C5) on FNAC 
that came out to be benign on histology. 
 
 
Positive FNAC will mean cases in which FNAC was 
able to detect correctly the final histologic diagnosis 
while negative FNAC are those where final histologic 
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For the purpose of proper statistical analysis, cases di-
agnosed as C4 and C5 were stratified together as malig-
nant while C2 and C3 were designated benign.  
 
We calculated the sensitivity and specificity of FNAC 
as a diagnostic procedure for breast masses, positive and 
negative predictive value of FNAC as a diagnostic pro-
cedure for the entire study. 
 
Table 2 Table of comparison of FNAC sensi-
tivity with histology (gold standard) 
                       HISTOLOGY  
POSITIVE NEGATIVE TOTAL 
FNAC  POSITIVE 158 0 158 
NEGATIVE 1 2 3 
TOTAL 159 2 161 
 
Sensitivity (Table 2) of FNAC is the ability of a test to 
identify correctly all those who have the disease Sensi-
tivity = [True positive / (True positive + false negative)] 
× 100% 
                  = [158 / (158+1)] × 100% = 158/159 × 100% 
                  = 99.4%.  
 
The specificity of FNAC is the ability of the study to 
identify correctly the candidates who do not have the 
disease.  
 
Specificity = [True Negative / (True Negative + False 
positive)] × 100%  
                  = [2 / (2+0)] × 100 = 100%.  
 
The positive predictive value (PPV) of FNAC was cal-
culated as the probability that the patient with a positive 
test has the disease in question. From this study this is 
calculated as: 
PPV = [True Positive / (True Positive + False Posi-
tive)] × 100% 
        = [158 / (158+0]) × 100 = 100%.  
 
The negative predictive value (NPV) of FNAC is the 
probability of a patient with a negative test not having 
the disease in question (malignancy). In this study this 
is:  
NPV = [True Negative / (True Negative + False Nega-
tive)] × 100%  





The earliest large scale use of Fine Needle aspiration 
Cytology FNAC as a diagnostic tool in the management 
of palpable masses was recorded in Memorial Hospital, 
New York, United States in the 1930s but it did not gain 
much encouragement in United States during the ensu-
ing years. The technique had resurgence in Scandinavia 
during the 1950s and 1960s, where it flourished before 
spreading to other parts of the world.8  
 
True FNAC for breast aspirations were first introduced 
in the beginning of 1960s by Franzen and Zajicek at the 
Karolinska Hospital in Stockholm.9 Being an oncolo-
gist, Franzen introduced standard May-Grunwald Giem-
sa stains on air-dried smears to allow for rapid interpre-
tation. Despite their success, it was not until 1980s that 
FNAC became widely used. The reasons included lack 
of confidence in the sensitivity and specificity of the 
procedure, fear of tumour implantation in the needle 
track, lawsuits, and surgeons not willing to relinquish 
the use of histological biopsy technique.10       
 
FNAC of the breast is commonly used as part of the 
diagnostic triad, which in addition to FNAC includes 
clinical breast examination and radiological evaluation 
(mammography and ultrasonography). The diagnostic 
accuracy is close to 100% when all three modalities 
favour a benign or malignant diagnosis.11 
 
Open surgical excision biopsy remains the diagnostic 
“gold standard” to which other methods must be com-
pared, with almost 100% sensitivity.12 However, com-
pared to FNAC and CNB, excision biopsy is expensive 
and associated with a greater degree of patient morbidi-
ty. Open biopsy leaves a visible scar that is cosmetically 
undesirable and may complicate mammographic follow 
up. In addition, open biopsy is associated with a signifi-
cantly longer “turn –around” time than that which ac-
companies FNAC. 13   
 
The “ideal” method of biopsy to diagnose breast cancer 
is debatable and should depend on the expertise availa-
ble in the unit, as well as the physical characteristics of 
the lump. FNAC is a reliable and relevant method for 
the pathological diagnosis of breast carcinoma in a de-
veloping nation like Malaysia. It is highly useful as an 
initial method of pathological assessment for palpable 
breast lumps. If the initial FNAC is inadequate, CNB 
can be a useful second line method of pathological di-
agnosis. Excision biopsy should be the last option to 




The sensitivity and specificity of the results have made 
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more beneficial to the patients. From the literature, the 
sensitivity ranges from 80% to 98% and the specificity 
may be up to 100%.14,15,16,17 There are some difficulties 
and limitations that need to be mentioned about FNAC. 
Both false-negative and false-positive results can oc-
cur.18 The most significant difficulty in making a diag-
nosis is the overlapping features of different lesions.19 
 
Dysplasia also has a role in the false negative results.20 
Small size of the tumour cells in certain histological 
types (lobular carcinoma, mucinous, tubular or medul-
lary carcinoma) may contribute to false negative results. 
Fine Needle Aspiration Cytology has been said to be 
able to give a definitive one stop assessment of a breast 
lump in about 90% of cases.1,4 From our study, defini-
tive diagnosis was available in 139 out of 161(86.3%) of 
cases excluding cases in C1, C3 and C4. If we add the 
suspicious cases (which return 95% accuracy) to the 
number, the total number of cases with correct FNAC 
evaluation would rise up to 98.1%. 
 
In cases where after a repeat sampling, one still gets 
acellular aspiration or suspicious/atypical cells, then a 
core needle biopsy is advised which in most instances 
will resolve the problem. Our experience over the past 5 
years is similar to that of other centres in resource poor 
settings. 3,4,7 The fact that breast FNAC is cheap, highly 
sensitive and specific and has a fast turn-around time 
had endeared the surgeons to this mode of diagnosis. 
 
In Egypt, a study was carried out to evaluate the effica-
cy of ultrasound guided FNACs by comparing the re-
sults with the corresponding definitive histological ex-
amination outcome as in our study. They also investi-
gated the role that core needle biopsy can play as a 
complementary diagnostic tool for breast cancer in se-
lected cases. The specificity and sensitivity of FNAC 
were 99.3% and 96.7%, respectively. The overall posi-
tive predictive values and negative predictive values 
were 99.3% and 96.7%, respectively. Aiming to maxim-
ize the preoperative diagnosis of cancer, they concluded 
therefore that it would be cost efficient and time saving 
to use FNAC as a first-line investigation to benefit from 
the wealth of cytological information yielded, followed 
by CNB in selected cases.7 
 
FNAC has become more reliable in the diagnosis of 
biological behaviour of breast masses.  Although its use 
has led reduction in the use of frozen-section histology 
by about 80%, erroneous diagnosis is still commoner 




FNAC is a  reliable, fast and accurate diagnostic method 
for the assessment of breast lumps. It has few managea-
ble complications and can be done on outpatient basis. 
 
It is our conclusion therefore that the surgeons and 
pathologists should continue to deploy the procedure 
towards the early detection of breast cancer. This will 
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